在输血的无塑性贫血和骨髓纤维化患者中,红细胞与免疫率的增加
1Department of Pathology, Duke University Hospital, Durham, North Carolina, USA.
Transfusion
|August 30, 2023
概括
红细胞 (RBC) 配免疫 (AI) 在依赖输血的患有无塑性贫血 (AA) 和骨髓纤维化 (MF) 的患者中更为常见. 这些患者经历了较高的红细胞AI率,这表明需要抗原匹配协议来减少并发症.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 输血医学 输血医学
背景情况:
- 红细胞 (RBC) 配免疫 (AI) 是红细胞输血的一个已知的并发症,导致配抗体的形成和输血风险.
- 需要输血的患者,包括患有无形性贫血 (AA) 和骨髓纤维化 (MF) 的患者,面临更高的红细胞AI风险.
- 有限的研究存在于RBCAI在特定的输血依赖人群,如AA和MF.
研究的目的:
- 在AA和MF患者中调查红细胞AI的流行率和alloantibody发病率.
- 为了将AA和MF患者的红细胞AI率与一般住院人口进行比较.
- 为了确定这些患者群体中开发的常见的alloantibodies.
主要方法:
- 在一家医院系统内进行了5年的回顾性审查.
- 收集的数据包括红细胞AI流行率,抗体发生率以及AA和MF患者的红细胞输血数量.
- 患者队列包括64名AA和93名MF患者.
主要成果:
- 与普通人群相比,AA和MF患者的RBCAI发病率显著增加 (分别为14.1%和12.9%),比一般人群 (1%-2%).
- 原发性髓纤维化患者的显着孤立RBCAI发病率为13.3%.
- 最常被发现的alloantibodies是抗E和抗K.
结论:
- 患有AA和MF的患者表现出高于一般住院人口的红细胞AI发病率.
- 实施抗原匹配输血协议可能对AA和MF患者有益,以减轻AI相关的并发症.
相关概念视频
Bone Marrow Sampling and Transplants
359
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
359
Blood Transfusion
606
Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
606
Blood Transfusion and Agglutination
10.9K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
10.9K
Disorders of Erythrocytes
979
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
979
Factors Affecting Erythropoiesis
3.3K
The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
3.3K
Rh Blood Group
1.5K
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
1.5K


